Literature DB >> 19054531

Persistence of abnormal cortisol levels in elderly persons after recovery from major depression.

Isabelle Beluche1, Isabelle Chaudieu, Joanna Norton, Isabelle Carrière, Jean-Philippe Boulenger, Karen Ritchie, Marie L Ancelin.   

Abstract

BACKGROUND: Cortisol hypersecretion is characteristic of acute clinical depression, but little is known in fully recovered, non-treated elderly persons with a lifetime history of depression. This study was designed to examine patterns of diurnal cycle of cortisol in an elderly cohort without current depression or treatment for depression according to whether the person has or has not experienced a previous episode of depression or co-morbid depression with anxiety.
METHODS: Cortisol secretion was evaluated in 162 community-dwelling elderly on a stressful and a non-stressful day (basal level). Past depression and anxiety disorders were assessed using a standardized psychiatric examination based on DSM-IV criteria (the Mini International Neuropsychiatric Interview).
RESULTS: Antidepressant-free persons with a history of non-co-morbid major depression (6.8% of the sample) showed basal cortisol hypersecretion compared to those with depression and anxiety (8.6%) or controls. Several hours after exposure to a stressful situation, controls showed a sustained increase in cortisol secretion, which was not observed in persons with a history of depression. Persons with a history of depression with anxiety showed a similar cortisol secretion at baseline to controls but a heightened response to stressful situation; a pattern comparable to that observed in subjects with pure anxiety disorders (16.7%).
CONCLUSION: An abnormal HPA response persists even after effective treatment for depression. A history of co-morbid depression and anxiety gives rise to changes characteristic of anxiety alone. Our findings suggest that cortisol abnormalities may be trait markers for vulnerability to depression and for the differentiation of depression and depression with co-morbid anxiety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054531     DOI: 10.1016/j.jpsychires.2008.10.011

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  19 in total

1.  Spiritual well-being, cortisol, and suicidality in Croatian war veterans suffering from PTSD.

Authors:  Sanea Mihaljević; Bjanka Vuksan-Ćusa; Darko Marčinko; Elvira Koić; Zorana Kušević; Miro Jakovljević
Journal:  J Relig Health       Date:  2011-06

Review 2.  Biological basis of depression in adults with diabetes.

Authors:  Shivam Champaneri; Gary S Wand; Saurabh S Malhotra; Sarah S Casagrande; Sherita Hill Golden
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

3.  Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.

Authors:  Eric J Lenze; David Dixon; Rose C Mantella; Peter M Dore; Carmen Andreescu; Charles F Reynolds; John W Newcomer; Meryl A Butters
Journal:  Int J Geriatr Psychiatry       Date:  2011-06-17       Impact factor: 3.485

Review 4.  Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.

Authors:  Muhammad Zahid Khan; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2017-03-13       Impact factor: 4.530

5.  Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy.

Authors:  Jason M Holland; Alan F Schatzberg; Ruth O'Hara; Renee M Marquett; Dolores Gallagher-Thompson
Journal:  Psychiatry Res       Date:  2013-08-14       Impact factor: 3.222

6.  Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly.

Authors:  Isabelle Jaussent; Jean Bouyer; Marie-Laure Ancelin; Tasnime Akbaraly; Karine Pérès; Karen Ritchie; Alain Besset; Yves Dauvilliers
Journal:  Sleep       Date:  2011-08-01       Impact factor: 5.849

7.  The moderating effect of the APOE [small element of] 4 allele on the relationship between hippocampal volume and cognitive decline in older depressed patients.

Authors:  Natalie Sachs-Erisson; Kathryn Sawyer; Elizabeth Corsentino; Nicole Collins; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2011-01       Impact factor: 4.105

8.  Depressive symptoms are associated with allostatic load among community-dwelling older adults.

Authors:  Roni W Kobrosly; Edwin van Wijngaarden; Christopher L Seplaki; Deborah A Cory-Slechta; Jan Moynihan
Journal:  Physiol Behav       Date:  2014-01-17

9.  Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.

Authors:  M L O Shea; L D Garfield; S Teitelbaum; R Civitelli; B H Mulsant; C F Reynolds; D Dixon; P Doré; E J Lenze
Journal:  Osteoporos Int       Date:  2013-01-29       Impact factor: 4.507

10.  Chronic and remitting trajectories of depressive symptoms in the elderly. Characterisation and risk factors.

Authors:  I Carrière; A Farré; C Proust-Lima; J Ryan; M L Ancelin; K Ritchie
Journal:  Epidemiol Psychiatr Sci       Date:  2016-01-15       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.